Idiopathic pneumonia syndrome (IPS) refers to diffuse lung injury which can occur following haematopeotic stem cell transplantation where neither an infectious nor non-infectious aetiology can be found.
The incidence of IPS is thought to be around 12% following haematopoetic stem cell transplantation.
Clinical presentation can vary from being asymptomatic to full blown acute respiratory distress syndrome. Its median onset time is around 40-50 days following transplantation, but there is an early peak in the first 14 days, followed by a lower but consistent incidence up to around 80-100 days.
Its aetiology is thought to be multifactorial inclusive of chemoradiotherapeutic insults and graft versus host disease 4. There are two main histopathological patterns
- interstitial pneumonitis
- diffuse alveolar damage
Plain radiograph / CT
- would typically show diffuse airspace and/or intestinal infiltrative opacification 4
- 1. Clark JG, Hansen JA, Hertz MI et-al. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am. Rev. Respir. Dis. 1993;147 (6_pt_1): 1601-6. doi:10.1164/ajrccm/147.6_Pt_1.1601 - Pubmed citation
- 2. Khurshid I. Postgraduate Medical Journal.78 (919): . doi:10.1136/pmj.78.919.257
- 3. Wiedermann HP. Toward an understanding of idiopathic pneumonia syndrome after bone marrow transplantation. Crit. Care Med. 1999;27 (9): 2040-1. Pubmed citation
- 4. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest. 1996;109 (4): 1066-77. Pubmed citation
- 5. Veys P, Owens C. Respiratory infections following haemopoietic stem cell transplantation in children. Br. Med. Bull. 2002;61 (1): 151-74. doi:10.1093/bmb/61.1.151 - Pubmed citation